Drug: INFLIXIMAB, RECOMBINANT Injury: Basal cell carcinoma Quarter: 2016Q3
Total Records: 2 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
123095595 | INFLIXIMAB, RECOMBINANT | Basal cell carcinoma | JANSSEN | 64.73 YR | M | 60 KG | 20160701 | US |
125371221 | INFLIXIMAB, RECOMBINANT | Basal cell carcinoma | JANSSEN | 0.00 | 0 | 20160707 | FR |
Total Records: 2 Number of Pages: 1